Deerfield Management Reveals Position in Newly Public Company Trivascular Technologies Inc (TRIV)

As a new filing with the Securities and Exchange Commission showed, Deerfield Management, a healthcare focused investment firm, managed by James E. Flynn, disclosed a new stake in Trivascular Technologies Inc (NASDAQ:TRIV), a company that began trading on April 16. The stake held by Deerfield amasses close to 632,700 shares, valued at almost $7.6 million.

Trivascular

Trivascular Technologies Inc (NASDAQ:TRIV) is specialized in production and sale of medical devices and technology for invasive treatment of abdominal aortic aneurysms. The company is currently conducting its IPO, during which it plans to sell a total of 6.5 million shares at a price of $12.00 apiece. The IPO price has been set below the price disclosed in one of the amendments to the S-1 form with the SEC, in which the company indicated a price of $15.00 per share.

Among the largest shareholders of the company, is New Enterprise Associates, which together with affiliates holds around 17.7%, followed by Delphi Ventures, which owns 14.2% together with its affiliates, among other investors which hold less significant positions.

Last week, Deerfield Management reported raising its exposure to Insmed Incorporated (NASDAQ:INSM), in which it now holds 3.04 million shares, equal to 7.75% of the outstanding stock. In fact, Mr. Flynn has been bullish on several companies since the beginning of the year, and reported increases in several of its holdings. At the same time the fund initiated positions in several healthcare companies, some of which also right after their IPO. One of them is Cara Therapeutics Inc. (NASDAQ:CARA), in which Deerfield disclosed ownership of 350,000 shares a couple of days after the company went public.

Disclosure: none

Recommended Reading:

James Flynn, Deerfield Management Boost Stake in Streamline Health Solutions Inc. (STRM)

James Flynn, Deerfield Management Step Up Interest In Alphatec Holdings Inc (ATEC)

Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!